Drug Master Files for: MOMETASONE FUROATE
✉ Email this page to a colleague
MOMETASONE FUROATE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 14991 | A | II | 5/26/2000 | HOVIONE FARMACIENCIA SA | MOMETASONE 17-FUROATE |
| 15063 | A | II | 9/29/2000 | TEVA PHARMACEUTICAL INDUSTRIES LTD | MOMETASONE FUROATE USP |
| 15187 | A | II | 12/7/2000 | WAVELENGTH ENTERPRISES LTD | MOMETASONE FUROATE |
| 16648 | A | II | 6/16/2003 | STERLING SPA | MOMETASONE FUROATE |
| 19023 | A | III | 12/9/2005 | 3M DRUG DELIVERY SYSTEMS DIV | MOMETASONE & FORMOTEROL COMBINATION PRODUCT PMDI ACTUATOR |
| 19781 | I | II | 9/20/2006 | SYMBIOTEC PHARMALAB PRIVATE LTD | MOMETASONE FUROATE |
| 20684 | A | II | 7/12/2007 | SYMBIOTEC PHARMALAB PRIVATE LTD | MOMETASONE FUROATE USP (MICRONISED) |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
